Page 2 - SAMRC AnnualReport 2025-26

CONTENTS

PART A PART B
GENERAL PERFORMANCE
INFORMATION INFORMATION

SAMRC’S GENERAL AUDITOR’S REPORT: FUNDING HEALTH INNOVATION 163
INFORMATION 3 PREDETERMINED OBJECTIVES 25
Grants Innovation and
LIST OF ABBREVIATIONS/ OVERVIEW OF PERFORMANCE 25 Product Development 163
ACRONYMS 3 Service Delivery Environment 25 GIPD Programmes and 163
Strategic Projects
FOREWORD BY Organisational environment 25 Grand Challenges
THE CHAIRPERSON 4 Key policy developments South Africa Programme 168
and legislative changes 25
A NOTE FROM Managing Vaccine Clinical Trials 180
THE PRESIDENT AND CEO 6 Progress towards achievement
of institutional Impacts and DIVISION OF RESEARCH
Outcomes 25 188
STATEMENT OF RESPONSIBILITY CAPACITY DEVELOPMENT
AND CONFIRMATION Institutional Programme Overview 188
OF ACCURACY FOR THE Performance Information 26
RCD Programme 188
ANNUAL REPORT 8
OUTPUTS, OUTPUT INDICATORS, RCD Scholarships Portfolio 190
ACHIEVEMENTS TARGETS AND ACTUAL RCD grant portfolio 192
AND HIGHLIGHTS 9 ACHIEVEMENTS 30

STRATEGIC OVERVIEW 12 RESEARCH PROGRAMMES
Our mandate 12 AND UNITS WITHIN THE SAMRC 36
Who we are 12 SAMRC STRATEGIC
Our vision 13 RESEARCH PROGRAMMES 38
Our mission 13
PROGRAMME 1: HEALTH
Our values 13 PROMOTION AND DISEASE
PREVENTION 38
LEGISLATIVE AND
OTHER MANDATES 14 PROGRAMME 2: MATERNAL,
Constitutional mandate 14 CHILD AND WOMEN'S HEALTH 68
Statutory and other mandates 14 PROGRAMME 3: HIV, AIDS, TB
AND OTHER COMMUNICABLE
ORGANISATIONAL STRUCTURE 15 DISEASES 76
OUR NEW TRANSFORMATION
PROGRAMME 4:
PLAN: 2025 – 2028 16
HEALTH SYSTEMS
STRENGTHENING 108
CHARTING A COURSE FROM
LANGUISHING TO FLOURISHING 18
PROGRAMME 5:
PUBLIC HEALTH INNOVATION 128
ENVIRONMENT AND CULTURE 18
PROGRAMME 6:
PARTNERSHIPS WITH BIOMEDICAL RESEARCH 146
OTHER COUNTRIES 20